Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03066778 |
|---|---|
| Brief Title: | A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) |
| First Submitted : | February 23, 2017 |
| First Submitted that Met QC Criteria : | February 23, 2017 |
| First Posted : | February 28, 2017 |
| Results First Submitted : | November 25, 2020 |
| Results First Submitted that Met QC Criteria : | November 25, 2020 |
| Results First Posted : | December 22, 2020 |
| Last Update Submitted that Met QC Criteria : | September 2, 2022 |
| Last Update Posted : | October 3, 2022 |